Aurora kinase inhibitor SNS-314, Purity ≥98%

Cat. No.: X23-10-ZQ485

Aurora kinase inhibitor SNS-314, Purity ≥98%

Synonym: SNS-314 Mesylate; 1146618-41-8; SNS 314 mesylate; SNS-314 (mesylate); KGW32FDY3U; 1-(3-Chlorophenyl)-3-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl]urea; Methanesulfonic acid; Aurora kinase inhibitor

  • CAS Number: 1146618-41-8
  • Compound CID: 24995523
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SNS-314, soluble in warmed DMSO and warmed ethanol and insoluble in water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A, Aurora B, and Aurora C.
Molecular Weight
527
Molecular Formula
C18H15ClN6OS2.CH4O3S
Targets
Aurora A: 9 nM; Aurora B: 31 nM; Aurora C: 3 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 80 mg/mL (151.79 mM); Water: Insoluble; Warmed ethanol: 1 mg/mL (1.89 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
SNS-314 can be used to research the triple inhibition of Aurora kinases A, B, and C in oncology.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.